We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New International Clinical Trial Register

By Biotechdaily staff writers
Posted on 28 May 2003
A new online service provides unique numbers to randomized controlled trials in all areas of healthcare and from all countries in the world. More...
This service, designed to address the current confusion experienced by the clinical trials community, is called the International Standard Randomized Controlled Trial Number (ISRCTN) Register.

Currently, several trials may have the same title, one may be reported in several places under different titles, and many trials are never reported. The new register assigns a unique number to each randomized controlled trial in order to track the trial unambiguously throughout its life cycle. The register is being launched after a successful pilot by the UK Medical Research Council and the UK Coordinating Committee for Cancer Research. To date, more than 80 organizations that have sponsored trials have already registered, and the database now contains more than 750 records.

Several trial registers are in existence with their own numbering schemes. Also, specific registers exist for diseases such as Alzheimer's and diabetes. The US National Library of Medicine has created a website providing details of trials in the United States. The new register is unique, however, since it is not limited to a specific disease or geographic area. Medical journals are being encouraged to allow authors to include their ISRCTN in any research they publish, so that the trials can be easily identified in databases such as MEDLINE and PubMed.

"Acting rather like the ISBN (International Standard Book Number) on the back of every book, the ISRCTN will simplify the identification of trials and provide a unique number that can be used to track all publications and reports resulting from each trial,” said Anne Greenwood, managing director, Current Controlled Trials Ltd. (London, UK), which developed the register. Registering details are provided on the company's website (www.controlled-trials.com).





Related Links:
Current Controlled Trials

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Urine Analyzer
respons® UDS100
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.